Nathan Davies Selected Research

Nathan Davies Research Topics

Disease

27	Dementia (Dementias) 04/2024 - 08/2013
12	Fibrosis (Cirrhosis) 04/2024 - 02/2015
8	Inflammation (Inflammations) 01/2023 - 04/2015
6	Liver Diseases (Liver Disease) 08/2022 - 03/2015
5	Acute-On-Chronic Liver Failure 04/2024 - 01/2020
5	Endotoxemia 01/2023 - 09/2011
5	Liver Failure 08/2022 - 04/2015
5	Death (Near-Death Experience) 12/2021 - 05/2014
4	Hepatic Encephalopathy 08/2022 - 01/2017
4	Neoplasms (Cancer) 01/2022 - 05/2014
3	Liver Cirrhosis (Hepatic Cirrhosis) 10/2021 - 01/2020
3	Acute Liver Failure (Fulminant Hepatic Failure) 01/2020 - 01/2012
3	Portal Hypertension 11/2017 - 07/2012
2	Parkinson Disease (Parkinson's Disease) 12/2023 - 10/2014
2	End Stage Liver Disease 01/2023 - 04/2015
2	Pneumonia (Pneumonitis) 01/2021 - 01/2016
2	Pain (Aches) 01/2021 - 07/2014
2	Hepatocellular Carcinoma (Hepatoma) 08/2020 - 03/2015
2	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 06/2020 - 03/2013
2	Infections 06/2020 - 01/2018
2	Hyperammonemia 01/2020 - 01/2017
2	Cognitive Dysfunction 01/2019 - 10/2014
1	Psychotic Disorders (Schizoaffective Disorder) 01/2022
1	Sarcopenia 01/2022
1	Confusion (Bewilderment) 09/2021
1	Sepsis (Septicemia) 04/2021
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2021
1	COVID-19 01/2021
1	Pressure Ulcer (Bedsore) 01/2021
1	Hepatitis 08/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Coma (Comas) 01/2020
1	Brain Edema (Cerebral Edema) 01/2020
1	Anthrax 01/2018

Drug/Important Bio-Agent (IBA)

4	LipopolysaccharidesIBA 04/2024 - 01/2020
4	AlbuminsIBA 01/2023 - 04/2015
4	salicylhydroxamic acid (SHAM)IBA 10/2021 - 02/2015
4	EndotoxinsIBA 01/2020 - 01/2016
3	AmmoniaIBA 08/2022 - 01/2017
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022 - 03/2015
3	CytokinesIBA 06/2020 - 01/2020
3	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2016
2	Carbon Tetrachloride (Tetrachloromethane)IBA 04/2024 - 12/2021
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2023 - 02/2015
2	Toll-Like Receptor 4IBA 01/2023 - 01/2020
2	Interleukin-8 (Interleukin 8)IBA 01/2023 - 09/2011
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2016
2	LigandsIBA 01/2023 - 01/2020
2	ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA 11/2022 - 01/2020
2	GalactosamineIBA 12/2021 - 01/2020
2	Caspase 3 (Caspase-3)IBA 08/2020 - 03/2013
2	ornithine phenylacetateIBA 01/2020 - 01/2017
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2017 - 01/2012
2	AntioxidantsIBA 01/2016 - 04/2015
1	CarbonIBA 04/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2024
1	propylene diquat (PDQ(+))IBA 12/2023
1	InflammasomesIBA 01/2023
1	Keratin-18 (Keratin 18)IBA 01/2023
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2022
1	Oxygen (Dioxygen)IBA 08/2022
1	Protons (Proton)IBA 08/2022
1	NeurotoxinsIBA 08/2022
1	BuffersIBA 04/2021
1	TerlipressinIBA 04/2021
1	CryogelsIBA 04/2021
1	benzoyl L-arginine methyl ester (BAME)IBA 01/2021
1	NitrogenIBA 01/2021
1	Syntex adjuvant formulationIBA 01/2021
1	AntibodiesIBA 08/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2020
1	Toll-Like Receptor 2IBA 08/2020
1	Interleukin-17 (Interleukin 17)IBA 06/2020
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 06/2020
1	ChemokinesIBA 01/2020
1	EnzymesIBA 01/2020
1	PrionsIBA 01/2020
1	CholesterolIBA 01/2020
1	Urea (Carbamide)FDA LinkGeneric 01/2020
1	Therapeutic UsesIBA 01/2020
1	Alkaline PhosphataseIBA 01/2020
1	Waste Products (Waste Product)IBA 01/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2018
1	Membrane Transport Proteins (Biological Pump)IBA 09/2018
1	Serum AlbuminIBA 09/2018
1	Dialysis SolutionsIBA 09/2018

Therapy/Procedure

14	Terminal Care (Care, Terminal) 01/2022 - 01/2014
10	Palliative Care (Palliative Therapy) 04/2024 - 08/2013
6	Ligation 04/2024 - 04/2015
4	Therapeutics 01/2019 - 02/2015
2	Enteral Nutrition (Feeding, Tube) 01/2023 - 01/2021
2	Long-Term Care 01/2022 - 02/2021
2	Patient Transfer (Patient Dumping) 09/2021 - 01/2020
2	Patient Care 01/2020 - 07/2014
1	Life Support Care 04/2024
1	Activities of Daily Living (ADL) 01/2022
1	Complementary Therapies (Alternative Medicine) 01/2022
1	Transjugular Intrahepatic Portasystemic Shunt 10/2021
1	Artificial Liver (Bioartificial Liver) 04/2021
1	Peritoneal Dialysis 09/2018